To Editor,
Cancer continues to be a major global health challenge, with low- and middle-income countries (LMICs) bearing a disproportionate burden of the disease. By 2030, nearly three-quarters of all cancer deaths are projected to occur in LMICs, underscoring the urgent need for effective strategies to bridge the gap between developed and non-developed countries.1 A multidisciplinary approach involving oncologists, radiotherapists, surgeons, and pathologists is crucial for optimal cancer management and treatment decision-making. Tumor board meetings, where experts convene to discuss treatment options, have proven instrumental in achieving accurate diagnoses, informed treatment choices, and improved patient outcomes.2
However, the accessibility of tumor board meetings remains a significant challenge, particularly for patients in remote areas who face limited access to specialized cancer treatments, transportation barriers, and financial constraints. Furthermore, even within specialized centers, disagreements between experts during face-to-face tumor board meetings can hinder decision-making. This is where digital technologies, exemplified by the increased use of telemedicine during the COVID-19 era, offer a promising solution. By conducting tumor board meetings virtually, healthcare professionals in underprivileged areas can remotely consult with experts from specialized centers, facilitating evidence-based decision-making, fostering collaboration between health centers, optimizing the allocation of healthcare resources, and reducing the associated costs and time burden for patients and professionals.
To illustrate the potential of virtual tumor boards, a study conducted in western Kenya implemented teleconsultation between a treating surgeon and three neurosurgeons from the United States of America using a web-based platform. The study successfully guided the treatment path of a 5-year-old child diagnosed with a challenging intracranial tumor with symptomatic hydrocephalus.3 Similarly, Mainguene et al examined the feasibility and effectiveness of virtual tumor boards, finding that they improved the accuracy of treatment decision-making for patients with advanced lung cancer and significantly reduced the time required to initiate treatment.4 Another study by Martiniuk et al explored the use of digital resources and virtual tumor boards for multidisciplinary discussions in pediatric oncology cases in rural and other low-resource settings, demonstrating that they led to improved clinical decision-making and increased the likelihood of appropriate treatment recommendations for pediatric cancer patients.5
Additionally, Davis et al compared online and face-to-face tumor boards in the United States of America, reporting a 46% increase in doctor attendance during virtual meetings.6 Similarly, Hammer and colleagues’ study in an academic healthcare cancer center in the United States demonstrated that a virtual ear, nose, and throat tumor board reduced the delay time for case discussions from 23% to 10%.7 Another study by Irwin et al evaluated the impact of a virtual tumor board on the management of cancer, showing that the virtual interventions address cancer care barriers for marginalized populations via collaborative models, leveraging technology, community partnerships, and addressing multi-level barriers. Cultivating trust and collaboration are key for equitable oncology advancement.8
Furthermore, a study conducted in Germany by Heuser et al examined the implementation of a virtual tumor board in a comprehensive cancer center. The study found that virtual tumor boards improved interdisciplinary communication, reduced the time to treatment decision, and facilitated the integration of precision medicine approaches.9 Similarly, a study by Esteso et al evaluated the use of virtual tumor boards in gastrointestinal oncology, claiming multidisciplinary tumor boards enhance cancer care, reducing disparities and costs, benefiting patients, and health systems.10 Moreover, Gebbia et al explored the implementation of virtual tumor boards for Lung cancer and demonstrated benefits include extended advantages of traditional MTB. Virtualization enhances participation, aids patient safety, promotes multidisciplinary interaction, and supports specialized treatment decisions in biomarker-driven strategies.11
While online tumor boards offer substantial benefits for patients in remote regions and serve as valuable training tools, they also present certain challenges. One of the key issues is the requirement for internet access and a suitable platform for participation. Ensuring the active participation and accountability of all team members throughout the meeting while maintaining secure communication platforms is another critical consideration.
Addressing these challenges necessitates the development of appropriate infrastructures, such as broadband networks and secure data transfer protocols. Furthermore, allocating funds to training and educational programs dedicated to the use of online tumor boards, establishing clear guidelines for their implementation, encouraging healthcare professionals to participate, simplifying health platforms for ease of use, accessibility, and security are essential steps toward maximizing the benefits of virtual tumor boards. Additionally, timely provision of patient information before meetings is vital to ensure adequate preparation and active engagement of all team members.
Conclusion
In conclusion, virtual tumor boards hold significant potential for improving cancer care, particularly for patients in remote regions, and can serve as valuable tools for physicians, especially in developing countries. However, overcoming challenges related to internet access, platform selection, and maintaining active participation throughout the meeting is critical. By investing in necessary infrastructures, training programs, and setting clear guidelines, healthcare systems can leverage the benefits of virtual tumor boards to enhance equity in cancer care.
Competing Interests
The authors have no competing interests to declare.
Data Availability Statement
Not applicable.
Ethical Approval
Not applicable.
Funding
Nil.
References
- 1.Pramesh CS, Badwe RA, Bhoo-Pathy N, Booth CM, Chinnaswamy G, Dare AJ, et al. Priorities for cancer research in low- and middle-income countries: a global perspective. Nat Med. 2022;28(4):649–57. doi: 10.1038/s41591-022-01738-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Specchia ML, Frisicale EM, Carini E, Di Pilla A, Cappa D, Barbara A, et al. The impact of tumor board on cancer care: evidence from an umbrella review. BMC Health Serv Res. 2020;20(1):73. doi: 10.1186/s12913-020-4930-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Henderson F Jr, Lepard J, Seibly J, Rambo W Jr, Boswell S, Copeland WR 3rd. An online tumor board with international neurosurgical collaboration guides surgical decision-making in Western Kenya. Childs Nerv Syst. 2021;37(2):715–9. doi: 10.1007/s00381-020-04744-x. [DOI] [PubMed] [Google Scholar]
- 4.Mainguene J, Basse C, Girard P, Beaucaire-Danel S, Cao K, Brian E, et al. Surgical or medical strategy for locally-advanced, stage IIIA/B-N2 non-small cell lung cancer: reproducibility of decision-making at a multidisciplinary tumor board. Lung Cancer. 2022;163:51–8. doi: 10.1016/j.lungcan.2021.12.004. [DOI] [PubMed] [Google Scholar]
- 5.Martiniuk A, Challinor J, Arora RS, Handayani SA, Lam C. Digital solutions to facilitate education, training and professional support for paediatric oncology and other health professionals in rural and other low-resource settings. Health Educ. 2022;122(2):232–59. doi: 10.1108/he-02-2021-0035. [DOI] [Google Scholar]
- 6.Davis CH, Ho J, Stephenson R, August DA, Gee H, Weiner J, et al. Virtual tumor board increases provider attendance and case presentations. JCO Oncol Pract. 2022;18(10):e1603–e10. doi: 10.1200/op.22.00158. [DOI] [PubMed] [Google Scholar]
- 7.Hammer RD, Fowler D, Sheets LR, Siadimas A, Guo C, Prime MS. A digital tumor board solution impacts case discussion time and postponement of cases in tumor boards. Health Technol. 2021;11(3):525–33. doi: 10.1007/s12553-021-00533-x. [DOI] [Google Scholar]
- 8.Irwin KE, Ko N, Walsh EP, Decker V, Arrillaga-Romany I, Plotkin SR, et al. Developing a virtual equity hub: adapting the tumor board model for equity in cancer care. Oncologist. 2022;27(7):518–24. doi: 10.1093/oncolo/oyac069. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Heuser C, Diekmann A, Schellenberger B, Bohmeier B, Kuhn W, Karbach U, et al. Patient participation in multidisciplinary tumor conferences from the providers’ perspective: is it feasible in routine cancer care? J Multidiscip Healthc. 2020;13:1729–39. doi: 10.2147/jmdh.s283166. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Esteso F, Tissera NS, O’Connor JM, Luca R, Huertas E, Sánchez Loria F, et al. Implementation of a virtual multicenter gastrointestinal tumor board to reduce cancer disparities in Argentina. World J Clin Oncol. 2022;13(6):423–8. doi: 10.5306/wjco.v13.i6.423. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Gebbia V, Guarini A, Piazza D, Bertani A, Spada M, Verderame F, et al. Virtual multidisciplinary tumor boards: a narrative review focused on lung cancer. Pulm Ther. 2021;7(2):295–308. doi: 10.1007/s41030-021-00163-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
Not applicable.